Rwrhdhwj

Beijing Fulong Kangtai Biotechnology Co., Ltd. was established in 2011 as a Sino foreign joint venture, jointly invested by a Chinese venture capital company and a biotechnology company from the United States. The company has multiple technical and management professionals with experience in the American pharmaceutical industry, and has hired several professors from well-known American universities as scientific advisors. We have technical service platforms for drug chemical synthesis, in vitro and in vivo drug screening, biochemistry, cell biology, immunotoxicology, skin toxicology, in vivo pharmacodynamics, etc. We can assist you in developing new pharmaceutical products for the treatment of cancer, autoimmune diseases, and other diseases, providing you with one-stop technical services& nbsp; At present, ELISA kits with strong specificity and high sensitivity for detecting cytokines such as IL-1alpha, IL-10, IL-17 have been developed, which can be used for clinical and basic medical research& nbsp; At the same time, we have developed a commercial artificial skin model that can replace animal experiments for detecting the corrosive or irritating effects of cosmetics, skin medications, detergents/cleaners, etc. on the skin. The research on alternative methods for animal experiments has a history of more than 40 years in foreign countries. The artificial skin model has been approved by the Alternative Methods Validation Centers in the United States and Europe as a validation test for cosmetic safety identification. We believe that our developed artificial skin model will be recognized by China's authoritative institutions and promote the research, validation, and application of alternative methods for animal experiments in cosmetics in China& nbsp; The chemical department of the company has developed practical production processes for multiple active pharmaceutical ingredients/intermediates, such as the intermediate of everolimus and alprostadil - digamma linolenic acid (DGLA, CAS: 7324-41-6), which can provide products ranging from grams to hundreds of kilograms& nbsp; The company is located in the newly built Beijing Yizhuang Biomedical Park (BYBP) in the Beijing Economic and Technological Development Zone, China. It has established extensive cooperative relationships with Peking Union Medical College Hospital, Jilin University, and other institutions. Integrity, dedication, and loyalty to science (practicality) are the essence of our corporate culture